Study: New Yorkers Support Recreational Cannabis, Just Not in Their Neighborhood
2.4 min readPublished On: March 19th, 2021By News Team
NEW YORK– While 61% of New York State residents support the legalization of adult-use recreational cannabis sales, more than half (52%) of those living in New York City would oppose its sale in their neighborhood. This disparity between general support and willingness to actually live near one is a significant problem when communities decide where, if anywhere, they want to allow cannabis retail sales.
With 61% of New York state residents believing a community should have the right to “opt-out” and ban marijuana sales in their community all together, the battle to site facilities is likely to require extensive community outreach and education efforts.
“Legalization is only the beginning of the battle,” said Patrick Fox, CEO of Consensus Strategies, a research and strategy firm with extensive experience in the siting of cannabis facilities, “The fight to find viable sites will be intense. We often hear from cannabis entrepreneurs who think that the level of support for legalization will translate into support for siting a retail or cultivation facility. It often does not.”
Local zoning and planning authorities will have the ability to decide where retail and cultivation facilities will be able to locate within their communities. They can choose to allow them in higher visibility general retail zones treating them like a liquor store. They can relegate them to more obscure, lower profile areas like an industrial park and restrict signage and visibility or they can ban the use in their community completely. The majority of New Yorkers (53%) believe that marijuana retail should keep a low profile and locate outside of high visibility retail areas.
Gaining support for cultivation facilities where marijuana is grown and processed will be even more challenging with 62% of those over 50 opposed to cultivation facilities in their neighborhood. 53% of Black/African-Americans and 61% of Hispanic/Latinos statewide oppose cultivation in their communities.
Other findings include:
New Yorkers are split on social equity and social justice. Support for license preferences for social equity applicants (51% support) and 50/50 on allowing those with former convictions for cannabis distribution to operate a legal cannabis shop.
More than a quarter (27%) of those supporting legalization say they are unlikely to ever shop there if they open.
More than 1 out of 10 (13%) of those opposed to legalization say they are likely to be a customer if they open.
53% support for home delivery.
Strong support (59%) for directing a portion of marijuana tax revenue to minority communities that were impacted by the war on drugs.
52% believe the law should allow people to legally grow a limited number of marijuana plants at home. 78% support from those 18-34.
The New York state survey was conducted by Consensus Strategies March 5-7, 2021. The sample consisted of 515 New York residents, with a Credibility Interval (CI)/margin of error (MOE) of +/- 4.3 percentage points. Data was collected using a mixed mode including mobile data collection via SMS-to-web, landlines using IVR, and an online panel.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
SALT LAKE CITY – (NORML)– The legalization of cananbis is associated with improvements in police clearance rates for multiple types of violent crimes, according to data published online ahead of print in The International Journal of Drug ...
LOS ANGELES- C3 Industries , a multi-state, vertically integrated cannabis company with headquarters in Ann Arbor, MI, has announced the launch of its new 15,000 square foot manufacturing facility in St. Louis, Missouri, which is expected to ...
WASHINGTON, D.C.– The US federal government has granted researchers studying the therapeutic potential of psychedelic medicine for the first time in 50 years. Indeed, the NIH was a major funder of the early research that ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more